Debt-to-equity of Adicet Bio, Inc. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Adicet Bio, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • Adicet Bio, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 21%, a 32% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Adicet Bio, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 21% +5% +32% 30 Sep 2025
Q2 2025 18% +2% +9.9% 30 Jun 2025
Q1 2025 17% -1% -3.8% 31 Mar 2025
Q4 2024 15% -2% -13% 31 Dec 2024
Q3 2024 16% 0% +2.5% 30 Sep 2024
Q2 2024 17% +3% +23% 30 Jun 2024
Q1 2024 17% +4% +34% 31 Mar 2024
Q4 2023 18% +6% +52% 31 Dec 2023
Q3 2023 16% +4% +38% 30 Sep 2023
Q2 2023 14% +1% +8.3% 30 Jun 2023
Q1 2023 13% -1% -6.4% 31 Mar 2023
Q4 2022 12% -5% -29% 31 Dec 2022
Q3 2022 11% -10% -47% 30 Sep 2022
Q2 2022 13% -11% -47% 30 Jun 2022
Q1 2022 14% -19% -58% 31 Mar 2022
Q4 2021 16% -77% -82% 31 Dec 2021
Q3 2021 22% +105% 30 Sep 2021
Q2 2021 24% +42% 30 Jun 2021
Q1 2021 32% +56% 31 Mar 2021
Q4 2020 93% +122% 31 Dec 2020
Q3 2020 -84% -64% -329% 30 Sep 2020
Q2 2020 -18% +2247% +99% 30 Jun 2020
Q1 2020 -24% -43% -224% 31 Mar 2020
Q4 2019 -28% -38% -384% 31 Dec 2019
Q3 2019 -20% -29% -302% 30 Sep 2019
Q2 2019 -2266% 30 Jun 2019
Q1 2019 19% 31 Mar 2019
Q4 2018 10% 31 Dec 2018
Q3 2018 10% 30 Sep 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.